CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
CELZNext catalyst
CELZ-201 Administration
Type 1 Diabetes
Get an email about CELZ's next catalysts
Track CREATIVE MEDICAL TECHNOLOGY HOLDINGS (CELZ) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (earnings).See the timeline
2 upcoming, 0 past
CELZ Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.24 | FQ end Sep/2026 | Call: tbd
CELZ-201 Administration Phase 2 Est. Readout
Primary completion for CELZ-201 Administration trial (NCT05626712) in Type 1 Diabetes
SourceMarket Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CELZ-201 Administration | Phase 2 | Type 1 Diabetes | - | - |
CELZ-201-DDT | Phase 2 | Chronic Low-back Pain | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s (CELZ) pipeline across Phase 2. Its lead program is CELZ-201 Administration (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s next FDA catalyst?→
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s (CELZ) next tracked catalyst is a Phase 2 readout expected Q1 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CELZ biotech catalysts?→
Add CELZ to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.